Valora Therapeutics Inc. is a biotechnology company and headquartered in Avalon BioVentures Accelerator in San Diego, California. Valora aims to develop novel classes of therapeutics through its proprietary glyco-immune checkpoint modulation technology, called AbLec (Antibody-Lectin chimera), and restore proper immunological competency in cancer, immune diseases, and other indications.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/20/24 | $30,000,000 | Seed |
Alexandria Venture Investments Avalon Ventures  Bregua Corporation Correlation Ventures TigerGene | undisclosed |
